1cl3: Difference between revisions
m Protected "1cl3" [edit=sysop:move=sysop] |
No edit summary |
||
Line 1: | Line 1: | ||
{{STRUCTURE_1cl3| PDB=1cl3 | SCENE= }} | {{STRUCTURE_1cl3| PDB=1cl3 | SCENE= }} | ||
===MOLECULAR INSIGHTS INTO PEBP2/CBF-SMMHC ASSOCIATED ACUTE LEUKEMIA REVEALED FROM THE THREE-DIMENSIONAL STRUCTURE OF PEBP2/CBF BETA=== | |||
{{ABSTRACT_PUBMED_10404215}} | |||
=== | ==Disease== | ||
[[http://www.uniprot.org/uniprot/PEBB_HUMAN PEBB_HUMAN]] Note=A chromosomal aberration involving CBFB is associated with acute myeloid leukemia of M4EO subtype. Pericentric inversion inv(16)(p13;q22). The inversion produces a fusion protein that consists of the 165 N-terminal residues of CBF-beta (PEPB2) with the tail region of MYH11. | |||
==Function== | |||
[[http://www.uniprot.org/uniprot/PEBB_HUMAN PEBB_HUMAN]] CBF binds to the core site, 5'-PYGPYGGT-3', of a number of enhancers and promoters, including murine leukemia virus, polyomavirus enhancer, T-cell receptor enhancers, LCK, IL3 and GM-CSF promoters. CBFB enhances DNA binding by RUNX1. | |||
==About this Structure== | ==About this Structure== | ||
Line 11: | Line 13: | ||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID:010404215</ref><references group="xtra"/> | <ref group="xtra">PMID:010404215</ref><references group="xtra"/><references/> | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Goger, M.]] | [[Category: Goger, M.]] |